| Bristol-Myers Squibb SA - Opdivo subkutan 600 mg/5 ml, Injektionslösung | | 70192 | | 01 | | Opdivo subkutan 600 mg/5 ml | | Injektionslösung | | L01FF01 | | Nivolumab | | 28.01.2026 | | |
| | Composition | | Lösung: nivolumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, saccharum, acidum penteticum, polysorbatum 80, methioninum, aqua ad iniectabile, q.s. ad solutionem pro 5 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose | additional_information |
|---|
| Nivolumabum | 600mg / 5ml | Lösung |
| | BAG: Active Agent |
|---|
| Nivolumabum |
| | | | Inactive agents |
|---|
| Acidum Penteticum | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Methionine | | Polysorbatum 80 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 2715.50 | 2969.70 | A | SL | No |
|
|
